This study aims to determine the key drives and future trend of 3D bioprinting in Malaysia. Both qualitative and quantitative method had been used in this study. A STEEPV (social, technology, economic, environment, political and value) analysis had been used to determine the drivers and to develop the scenario of 3D bioprinting in Malaysia. A total of 384 questionnaire had been distributed to medical industries with a response rate of 37.26%. Impact-uncertainty had been utilized in the second phase of the study. The top two drivers found were availability of funding for 3D bioprinting adoption and the focus of medical researcher on 3D bioprinting. Four scenarios had been proposed at the end of the study, which is prosperous of 3D bioprinting, sluggish of 3D bioprinting adoption, deficiency of funding, and destructibility of technology. This paper provided additional knowledge about future trend of 3D bioprinting in Malaysia.
3D bioprinting, STEEPV, foresight
Optimization of Polysaccharide Hydrocolloid for the Development of Bioink with High Printability/Biocompatibility for Coextrusion 3D Bioprinting.
Lim W, Shin SY, Cha JM, Bae H
Polymers. 2021; 13(11):
Development of a chitosan and hyaluronic acid hydrogel with potential for bioprinting utilization: A preliminary study.
Vieira de Souza T, Malmonge SM, Santos AR
Journal of biomaterials applications. 2021; (): 8853282211024164
In Vitro Glioblastoma Models: A Journey into the Third Dimension.
Paolillo M, Comincini S, Schinelli S
Cancers. 2021; 13(10):
Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement.
Coban MA, Morrison J, Maharjan S, Hernandez Medina DH, Li W, Zhang YS, Freeman WD, Radisky ES, Le Roch KG, Weisend CM, Ebihara H, Caulfield TR
Biomolecules. 2021; 11(6):
Double network laminarin-boronic/alginate dynamic bioink for 3D bioprinting cell-laden constructs.
Amaral AJR, Gaspar VM, Lavrador P, Mano JF
Biofabrication. 2021; 13(3):